This post is from a suggested group
Therapeutic Approaches and Unmet Clinical Needs Driving the Global Cervical Dystonia Market: Botulinum Toxin and Emerging Drug Candidates
The Cervical Dystonia Market, focused on the treatment of a painful and debilitating neurological movement disorder characterized by involuntary contractions of the neck muscles, is heavily dominated by pharmaceutical interventions. Cervical dystonia, also known as spasmodic torticollis, significantly impairs a patient's quality of life, leading to chronic pain, abnormal head postures, and functional disability. The primary and most effective treatment remains the localized injection of botulinum toxin (BoNT), which temporarily paralyzes the overactive muscles, providing symptomatic relief for several months. Consequently, the market growth is intrinsically linked to the uptake, accessibility, and efficacy of various BoNT formulations and the expertise of neurologists trained in administering these injections. Key market drivers include the increasing prevalence of neurological disorders globally, a greater understanding and diagnosis of dystonia subtypes, and the expansion of insurance coverage…